Carregant...
An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is one of the most widespread degenerative disorders in elderly people. A 90-day, open-label clinical study was conducted in 40 patients, aged 50 years or older, with early-stage dry-type AMD to evaluate the safety and efficacy of Macumax(®), a novel mixture of...
Guardat en:
| Publicat a: | J Med Food |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mary Ann Liebert, Inc., publishers
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8140349/ https://ncbi.nlm.nih.gov/pubmed/33180005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jmf.2020.0097 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|